Summit Therapeutics



Description: 

Summit develops treatments for rare and infectious diseases. The target Duchenne muscular dystrophy, a fatal genetic muscle wasting disease, and the infectious disease caused by the bacteria C. difficile.

Location(s): 
Headquarters
Abingdon OXF
United Kingdom